Aptahem AB (publ) (NGM:APTA)

Sweden · Delayed Price · Currency is SEK

0.3490

+0.0270 (8.39%)

At close: Sep 30, 2026

Aptahem AB Earnings Call Transcripts

Fiscal Year 2025

Status Update
A lead RNA aptamer for sepsis is advancing toward phase 2, with strong preclinical and phase 1 data. U.S. listing preparations are underway to access better valuation and regulatory incentives, while partnerships and expanded IP are being pursued for broader impact.

Read full transcript →

Press release